Better monitoring, delivery systems needed for anti-VEGFs

I do not personally perform intravitreal anti-VEGF injections, but I have many patients, friends and family members of friends who are being or have been treated. I have also taken the time to read the considerable literature in the field and have personally participated in many corporate medical advisory boards discussing the topic. So, I am no expert, but I have a few thoughts.
Intravitreal anti-VEGF injections for wet or exudative age-related macular degeneration are a truly disruptive, unexpected and amazing advance in our treatment of AMD. In the FDA (Read more...)

Full Story →